WTEU-M Female leadership in Medsensio, a digital health technology startup
- Coordinator
- Medsensio AS, Norway
- Runs
- 1 June 2023 to 29 February 2024
- Status
- Finished
- EU funding
- €75k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- Coordination and Support Action
- Grant agreement
- 101114412
What the project is doing
In the project's own words, from its summary on CORDIS.
Medsensio was founded in 2017 as a spinout from a research project in health data analysis at UiT the Arctic University of Norway, classifying lung and heart sounds and additional parameters from Norway's largest population study known as the Tromsø study. We saw an opportunity how AI and machine learning could be used to successfully analyze large amounts of data at expert-level performance. And we saw how remote patient monitoring of chronic lung and heart patients, producing large amounts of data, could benefit from technology like ours.
Medsensio offers a digital care solution which brings AI into screening, monitoring and predictions in chronic lung and heart disease management for improving patient outcomes and reducing cost. Our product is now ready for regulatory compliance under MDR and we are preparing for market launch in 2023.WomenTechEU will provide access to mentoring and networks to support our female CEO in building a strong and gender balanced team, leading it through the early market phase.
Furthermore, it will make Medsensio better prepared for realising its market and growth potential:•Boosting our expertise in handling negotiations and closing accounts for establishing partnerships, profiling potential customers for an efficient sales process, refining our marketing and sales tactics;•Expanding collaboration and streamlining communication in the team, with potential investors, customers, collaborators, our broader innovation community;•Reinforcing our capacity in attracting partners, broaden the prospect of new collaborations across Europe and worldwide, thereby strengthening our market position;•Exposing us to new investors within medtech and digital health, and helping to improve attractiveness of our investment case.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Medsensio AS | Troms | Norway | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI